CanDo

Candoo Pharmatech is a private Canadian pharmaceutical development and manufacturing company focused on advanced drug delivery, formulation development, and related analytical services. The company works on generic, 505(b)(2), and innovative pharmaceutical products and supports both small molecules and larger molecules through preformulation, analytical development, dissolution development, and manufacturing services. Its core positioning appears to be as a technology-driven CRO/CDMO rather than a therapeutics developer with a disclosed proprietary clinical pipeline. Candoo emphasizes complex oral dosage forms, solubility and bioavailability enhancement, and targeted drug release, and it has highlighted cGMP-audited operations and FDA approval of at least one first-to-file generic product for a client or internal program. Overall, the business is best understood as a formulation and drug-delivery-focused pharma services company operating at commercial service stage.